After more than a decade of clinical verification, the TB-IGRA product of Wantai Biopharm has had over a hundred Chinese and international papers published. It has served nearly a thousand customers, with an annual testing volume of over one million samples. It is also widely applied in public health fields such as the construction of tuberculosis-free communities, student physical examinations, customs quarantine, and prison screenings.

In 2022, it was recommended by the World Health Organization (WHO) for the diagnosis of tuberculosis infection. In 2024, Wantai Biopharm became a long-term cooperative supplier of the United Nations Office for Project Services (UNOPS). As a leader in the industry, the TB-IGRA product of Wantai Biopharm has contributed “Chinese wisdom” to global tuberculosis prevention and control with its excellent quality.